News

How have the pharmaceutical industry and academic guild interests shaped the evolution of psychiatry? Lisa Cosgrove, PhD, has something to say about it.

Pseudopatients and their discontents: an historical perspective.

When we meet a new patient who presents with "classic" symptoms, there are challenges described in this brief video.

What can psychiatrists in the US do to better prepare themselves and their patients for potential natural disasters? A research psychiatrist answers that question and more in this Psychiatric Times exclusive.

After receiving complaints, the FDA’s Office of Prescription Drug Promotion rebukes the pharmaceutical company for misleading advertising.

Chronotherapy presents a unique tool to add to the armamentarium of available modalities for management of non-seasonal depression. Clinicians should be familiar with its application and be able to implement it in recalcitrant sufferers.

The FDA accepts a New Drug Application for novel antidepressant.

This review highlights an important diagnostic and therapeutic task: the importance of differentiating true bipolar disorder/obsessive-compulsive disorder comorbidity from BD with secondary OCD.

Although the current generation of antidepressants extends back to the late 1980s, efforts to describe the dose-response relationship for treatment of major depressive disorder continue. More in this research update.

High traditional masculinity (HTM) men are more likely to die by suicide than non-HTM men, but they are less likely to report suicide ideation.

Depression, suicidal ideation, self-harming behaviors, and anxiety, as well as lower reaction time and cognitive decline, were found in patients with celiac disease, according to a recent study

Despite heterogeneity in symptoms, there is growing realization that common neurobiological processes may contribute to OCD vulnerability and its persistence.

The articles in this Special Report focus on the interplay between trauma and its consequences, including violent behaviors, substance use disorders, and stroke. Taken together, the articles may contribute to a better understanding of-and treatment development for-patients exposed to trauma.

Ultimately, the decision about involuntary treatment is about risk, not predictable outcomes. In many cases, however, these decisions are much more difficult and, until our crystal balls arrive, our best efforts may still fall short.

Psychotic violence is associated with primary psychotic disorders such as schizophrenia, schizoaffective disorder, and bipolar disorder. While it may be that psychotic violence is the least common type of violence in inpatient environments, it is also the most treatable.

The goals of psychotherapy education in medical school should be based on these seven ideals.

We often hear about seasonal affective disorder, but we don’t talk much about “winter woes.” Amaryllis offers something for everyone, for it encourages celebrations on many occasions, over as many months.

This generation of young people may have a unique risk of exposure to stress and researchers and clinicians are increasingly concerned about the long-term health consequences of such chronic exposure for young adults.

When we find ourselves in the half-tested world of off-label therapies, what’s a psychiatrist to do?

Over the past two decades, deaths associated with alcohol abuse have increased, but little data point to demographic changes.

My hacker stole my identity crisis.

Access to care has improved-especially for low-income and vulnerable populations-which has resulted in better health outcomes.

Drug companies are investing more to study psychiatric disorders, and there may be novel treatments in the near future.

A hypothetical first conversation with a non-binary person . . . One of us would be feeling nervous and the other certain-a phenomenon not unfamiliar to a psychiatrist, only here the roles would be reversed.

A phone rings on stage like a flashback and we return to our fantasy that characters can die and revive, that the show must go on . . .

Although 6 months is the recommended duration for buprenorphine treatment, many patients discontinue within a few weeks or months of treatment.

James L. Knoll IV, MD, analyzes the ethical and legal duties of psychiatrists treating substance use disorders.

With the help of psychotherapy, something from the deep unconscious helped cure her depression, forge her character, and guide her to a sense of peace.

The treatment of bipolar disorder changed in ways big and small in 2019. More in this summary.

The costs, risks, and considerations involved in treating addiction have upped the ante, as illustrated in this case.